REGISTER FOR TOUCH BRIEFINGS |
|
|
|
Register for touch briefings
|
|
|
|
|
|
|
|
Touch Briefings welcomes editorial submissions for inclusion within our print reports and website from industry practitioners.
|
|
|
|
|
|
EUROPEAN ONCOLOGICAL DISEASE 2006 ISSUE II - JANUARY 2007 |
|
Contents:
Contents
Advisory Panel
Foreword
|
The Price of Successful Research
Professor John Smyth President, Federation of European Cancer Societies (FECS)
|
Breast Cancer
|
|
Any Progress in 2006 in Breast Cancer in the Elderly?
Matti S Aapro Executive Director, International Society for Geriatric Oncology (SIOG) and President, Multinational Association for Supportive Care in Cancer (MASCC)
|
|
|
Aromatase Inhibitors in Metastatic Breast Cancer
J Michael Dixon Consultant Surgeon and Senior Lecturer in Surgery, Edinburgh Breast Unit, Western General Hospital, UK
|
|
|
Aromatase Inhibitors – The New Standard for Postmenopausal Women with Hormone-responsive Breast Cancer
Raimund Jakesz Chairman, Division of General Surgery, Vienna Medical School, and Coordinator, Austrian Breast & Colorectal Cancer Study Group (ABCSG)
|
|
|
The Risk of Early Recurrence and Distant Metastases: Lessons from the Monotherapy Adjuvant Aromatase Inhibitor Trials with a Focus on BIG 1–98
Hope S Rugo Clinical Professor of Medicine, Director, Breast Oncology Clinical Trials Program, University of California San Francisco Comprehensive Cancer Center
|
|
|
Reducing the Risk of Late Relapse in Postmenopausal Women with Hormone-sensitive Breast Cancer – Extended Adjuvant Letrozole
Melinda Wu1 and Paul E Goss2
1. Research Assistant, University of Toronto, and
2. Professor of Medicine, Harvard Medical School and Director of Breast Cancer Program, Massachusetts General Hospital Cancer Center
|
Metastatic Bone Cancer
|
|
Rational Use of Bisphosphonates for the Management of Patients with Breast and Prostate Cancer
Jean-Jacques Body Head, Internal Medicine Clinic and Endocrinology/Bone Diseases Unit, Institut Jules Bordet
|
Liver Cancer
|
|
Radioembolisation – A New Treatment for Primary and Secondary Liver Tumours
Bruno Sangro Director, Liver Unit, Department of Internal Medicine, Clinica Universitaria
|
Colorectal Cancer
|
|
Systemic Treatment in Colorectal Cancer
Hans-Joachim Schmoll Head, Department of Haematology and Oncology, Martin Luther Halle-Wittenberg University Hospital
|
Gastrointestinal Stromal Tumours
|
|
Managing Resistance to Gastrointestinal Stromal Tumours
Jean-Yves Blay,1,3 Philippe Cassier,1 Armelle Dufresne,1 Jerome Fayette,1 Pierre Paul Bringuier,1 Isabelle Ray-Coquard,2 Laurent Alberti,2 and Severine Tabone-Eglinger2
1. Hôpital Eduord Herriot, Unité d’Oncologie Médicale,
2. INSERUM U590 Centre Léon Bérard, and 3. Départment de Médicine, de Chirurgie et d’Anatomopathologie, Centre Léon Bérard
|
|
|
Long-term Disease Control with Imatinib Treatment in Metastatic Gastrointestinal Stromal Tumours
Margaret von Mehren Director of Sarcoma Oncology, Member of the Department of Medical Oncology, Fox Chase Cancer Center
|
|
|
Imatinib Efficacy in Gastrointestinal Stromal Tumours
Heikki Joensuu Department of Oncology, Helsinki University Central Hospital, Finland
|
|
|
Early Gastrointestinal Stromal Tumour Resection and Adjuvant Therapy with Imatinib
Peter Hohenberger Director of Surgery, Department of Surgery, Division of Surgical Oncology and Thoracic Surgery, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Heidelberg, Germany
|
Molecular Diagnostics for Cancer
|
|
Molecular Diagnostics for Haematological Cancer
Christine J Harrison Professor, Cancer Cytogenetics, Director, Leukaemia Research Cyogenetics Group, Cancer Sciences Division, University of Southampton
|
|
|
Molecular Diagnostics and Risk-stratification in Chronic Lymphocytic Leukaemia
Stephan Stilgenbauer and Hartmut Döhner Department of Internal Medicine III, University of Ulm
|
|
|
Molecular Diagnostics
Heather L McArthur and Monica N Fornier Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York
|
Chronic Lymphocytic Leukaemia
|
|
New Developments in the Treatment of Chronic Lymphocytic Leukaemia
Robin Foa Professor of Hematology, Division of Hematology, Department of Cellular Biotechnologies and Hematology, University of Rome ‘La Sapienza’
|
Non-Hodgkins Lymphoma
|
|
Therapeutic Options in Refractory or Relapsed CD20-positive Follicular Lymphoma
Martin Dreyling Head, Lymphoma Section, Department of Medicine III, University Hospital Großhadern, Ludwig Maximilians-University
|
Radiotherapy & Imaging
|
|
Compensator-intensity-modulated Radiotherapy – Traditional Tool for Modern Application
Sha Chang Associate Professor and Chief of Physics & Computing Division, Department of Radiation Oncology, University of North Carolina Medical School
|
|
|
Current Status of Four-dimensional Computed Tomography for High-precision Radiotherapy
Suresh Senan and Frank J Lagerwaard Professor of Clinical Experimental Radiotherapy and Radiation Oncologist, Vrije Universiteit, Amsterdam
|
|
|
Proton Beam Radiation Therapy – From Physics to Clinical Indications
Damien C Weber Section Chief of Central Nervous System and Paediatric Tumours, Department of Radiation Oncology, Geneva University Hospital
|
Tumour Markers
|
|
The TuBaFrost Project – A European Virtual Tumour Tissue Bank
Peter Riegman Head, Erasmus MC Tissue Bank, Molecular Diagnostics Unit, Department of Pathology, Erasmus Medical Center
|
|
|
Tumour Markers in Lung Cancer
Rafael Molina, Xavier Filella and Josep M Augé Oncobiology Unit, Laboratory of Biochemistry and Genetics, IDIBAPS Hospital Clinic
|
Cancer-related Nutrition
|
|
The Role of Eicosapentaenoic Acid in the Treatment of Cancer Patients
Attilio Giacosa and Mariangela Rondanelli Policlinico of Monza, Milan and University of Pavia
|
Technology & Services Section
|
|
|
|
|
